Company intelligence / Profile preview

MicroBioSensor

Manchester, United Kingdommicrobiosensor.co.uk ↗

Ownership: Private
Development stage: Other

Overview

MicroBioSensor has developed disposable, point-of-care diagnostic devices that rapidly detect early-stage bacterial infections and provide guidance on effective antibiotics. The technology is designed to be simple, robust, inexpensive, and suitable for use in vulnerable patient populations such as those on peritoneal dialysis or with chronic wounds. The company’s products aim to improve outcomes by enabling earlier intervention and supporting antimicrobial stewardship.[1][6][8][10]

Therapeutic areas: Infectious Diseases
Modalities: DeviceIn vitro diagnostic device (IVD)
Industry: Metabolite Diagnostics

Partnerships

No major pharmaceutical partnerships disclosed publicly. Some commercial partnerships with healthcare providers are implied.[2]

Beyond the preview

Go deeper on MicroBioSensor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroBioSensor.

Explore the full profile